Outlook Therapeutics Inc (NASDAQ:OTLK)

1.29
Delayed Data
As of Jul 02
 +0.01 / +0.78%
Today’s Change
0.50
Today|||52-Week Range
2.89
+118.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues5.2M3.0M3.8M3.1M
 
 
 
 
 
Depreciation And Amortization1.8M2.4M2.7M3.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.0M52.3M37.0M25.5M
 
 
 
 
 
Research And Development38.9M33.1M23.8M18.5M
 
 
 
 
 
Total Operating Expenses51.8M54.7M39.7M28.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.6M-51.8M-35.9M-25.4M
 
 
 
 
 
Extraordinary Credit0.000.003.2M1.0M
 
 
 
Extraordinary Charge0.000.000.00-5.5M
 
 
Interest Expense On Debt2.3M1.5M5.6M3.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-48.9M-53.2M-38.3M-33.7M
 
 
 
 
 
Income Taxes-190.1K-103.0K-501.5K-3.6M
 
 
 
 
 
Minority Interest-1.3M0.000.000.00
 
 
Preferred Dividend-5.6M-9.8M0.00-1.9M
 
 
 
 
Net Income-47.4M-53.3M-40.0M-46.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6M2.2M3.0M4.9M
 
 
 
 
 
Shares To Calculate EPS Diluted2.6M2.2M3.0M4.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$20.29-$29.36-$14.40-$9.76
 
 
 
 
 
EPS Diluted-$20.29-$29.36-$14.40-$9.74